Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.
Address
3805 OLD EASTON ROAD
DOYLESTOWN, PA 18902
Founded
2002
Number of Employees
7
Website
http://www.aprea.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)